Join host Lindsey Smith and other Osmosis team members for a global conversation about improving health and healthcare with prominent figures in education and healthcare innovation such as Chelsea Clinton, Mark Cuban, Dr. Ashish Jha, Dr. Eric Topol, Dr. Vivian Lee and Sal Khan, as well as senior leaders at organizations such as the CDC, National Institutes of Health, Johns Hopkins University, WHO, Harvard University, NYU Langone and many others.
On this episode of Raise the Line, we’ll introduce you to a relatively new company in the digital health space focused on treatment-resistant mental health patients, which constitute about 30% of peo…
If you were to name one thing that could simultaneously increase patient satisfaction and reduce provider burnout, would empathy come to mind? Well, based on research published in peer-reviewed journ…
The value of early detection is perhaps greater for cancer than many other diseases because it remains the second leading cause of death worldwide. On this episode of Raise the Line we're going to le…
On this episode of Raise the Line, we have the privilege of hearing from one of the nation's top healthcare leaders, Dr. Joshua Gordon, who is the director of the National Institute of Mental Health.…
The Crucial Role of Psychedelic Therapy Guides - Mary Cosimano, Former Director of Guide and Facilitator Services at The Johns Hopkins Center for Psychedelic and Consciousness Research
All of the prom…
“We're really heading to a cliff when it comes to those expressing interest in healthcare careers,” cautions today’s Raise the Line guest Geoffrey Roche, director of Workforce Development in North Am…
Active and fun are rarely the first words associated with medical education, but today’s Raise the Line guest, Dr. Amin Azzam, contends learners get the most value when they can engage with their edu…
“When we say ‘treatment for menopause,’ it implies that menopause is a disease, when really it’s a normal and expected time of life,” says Dr. Anna Barbieri, an integrative medicine physician and spe…
We've been careful on Raise the Line to use the term psychedelic-assisted therapy because, as we've heard from previous guests, these compounds are best administered in the context of a therapeutic r…
“I really have challenged the students that have graduated from Duke the last couple of years to consider being ambassadors for science and for communication of what is good science,” says Dr. Mary K…
Instead of fretting about AI replacing jobs humans currently do, Dr. Nigam Shah is urging people to adopt a perspective about the technology that echoes President John Kennedy’s famous charge in his …
“What's really exciting and scary in medical education right now is we're seeing large language models enter the scene,” says today’s Raise the Line guest Dr. Adam Rodman, who is well-placed to make …
When Munjal Shah and his colleagues chose to use Hippocratic in the name of their new AI-based company, it wasn’t just about signaling their product was involved with healthcare, it was also intended…
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
You’re going to hear something in this episode of Raise the Line that you most likely have never heard before: what DNA sounds like. Our guests today all had an interest in musically representing DN…
“I see health systems being systematically disintermediated by certain payers and some tech companies who are eager to take the easy stuff and leave health systems with really complex, sick and often…
While it’s encouraging that efforts to provide culturally competent care have gained a foothold in the wake of COVID, today’s Raise the Line guest says it is time to expand the conversation to encomp…
Our focus on the renaissance in research into psychedelics continues on this episode of Raise the Line, but instead of looking at their potential therapeutic applications, we're going to hear about u…
“I'm betting it's going to be more good than bad, but I have some big concerns about where things are headed,” warns Dr. Matthew Johnson of Johns Hopkins University when prognosticating about what im…